Young Joseph R's Form 4 filing
Vera Therapeutics, Inc. (VERA) · filed Sep 14, 2026
- Accession no.
- 0001861684-26-000006
- Filed
- Sep 14, 2026, 4:28 PM ET
- Trade date
- Sep 11, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Young Joseph RCIK 0001861684 | Officer (SVP, FINANCE, CHIEF ACCT OFFCR) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Class A Common Stock | MOption exerciseAcquired | +5,000 | $3.94 | +$19,698 | 80,754 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Class A Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 33,589 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.